Month: April 2022

Categories
Ask Utopia Silver

Sale Inquiry

Hi Utopia,
I absolutely have fallen in love with Gold & Silver!!  Thank you!  I noticed that you have sales occasionally.  Do you advertise your sales in advance?  Perhaps when your next sale may be?Thanks!!

 *****

Hi Jeanne,
We have sales of 25-50% Off regularly every month. We usually announce them via our Silver Bulletin Health News email or you may check at http://www.silverbulletin.utopiasilver.com/.

You are appreciated in Utopia.

Categories
Ask Utopia Silver

Knee Surgery

Hi Ben,
I had a complete replacement of my left knee last month at Audie Murphy VA Hospital in San Antonio. Have a lot of rehab physical therapy to do. I was afraid of getting an infection while in the hospital so I took the therapeutic doses of Advanced Colloidal Silver for several weeks prior to surgery. So far no infection what-so-ever.Robert in Texas

*****

Hi Robert,
I would never have surgery without doing a therapeutic colloidal silver and Enzyme protocol for several days prior to the procedure. I had surgery a couple of years ago to repair a lower abdominal muscle tear from weigh lifting which had resulted in a hernia. I was more afraid of a possible bacterial staph infection than I was of the surgery. So three days before surgery I started doing therapeutic amounts of colloidal silver- about 1 ounce every 2-3 hours (4-6 ounces each day). The three days, not only increased the silver content in my blood, but also gave my body time to adjust to the intense silver therapy.Additionally, I was also doing mega doses (4-5 capsules) of Enzymes morning and night 3 days prior to the surgery also. The day of surgery, I did 2 more ounces of colloidal silver when I awoke that morning and another 4 ounces after arriving at the hospital.

My after surgery protocol was 2-4 ounces of colloidal silver per day for 3 days as well as continuing the mega Enzyme therapy as before surgery for another month. After 3 days, I averaged about 1 ounce of colloidal silver per day for the next month.

Needless to say there was absolutely no infection and the healing was rapid. I only took a two pain pills the first night after surgery and none after that.

Thanks for the testimonial and the heads up on protecting yourself from the dangers of surgery.

Ben in Utopia

Categories
Customer Testimonials

Canine Skin Infection

Hi Utopia,
My 13 yr old dog has always had issues with bacterial skin infections and bad breath. Numerous vet visits for antibiotics and money spent had healed but the infection always comes back on her skin with large scabby, smelly, sores.
She had a permanent loss of hair on her tail and hair loss at her backend. The last alternative (after 12 yrs) was to go to a doggie dermatologist for a biopsy, spend hundreds to find the right medicine. So my Mom tells me about Utopia Silver and gives me a spray bottle to try. I was skeptic but Mom does not lie so everyday I would spray her mouth 2 shots and then spray her infected eyes and skin. Over the course of 2 months her hair grew back on her tail, her backend, she started to play like a puppy, eyes bright and clear, and skin infection cleared up. I was/am amazed! Thank you Utopia Silver Co!! I can’t thank you enough for what your product has done for my dog and my wallet. I shared my story today with friends who have similar stories and dogs with ear infections and they are ordering also. I am a new customer so I will call you tomorrow to place my order!  A must to have on hand.Donna in California

Categories
Featured Articles Silver Archives

Silver Clinical Case Studies

Following are a number of clinical studies concerning the use of silver in various forms, from silver anti-microbial wound dressings to anti-microbial silver polymer for the treatment of venous leg ulcers to the use of ionic silver to promote healing.

1. Gibbins, Bruce Ph.D., AcryMed, Inc., Portland, OR April 2000
Pre-clinical and Clinical Evaluation of a New Silver Anti-Microbial Chronic Wound Dressing ”

2. Nametka, Mary, RN, MSN, CS CWS, WCN, Associates in Wound Care, Kenosha, WI Oct. 2000
A Hydrophilic Silver Antimicrobial Wound Dressing for Site Preparation and Maintenance of Human Skin Equivalent Grafts to Venus Leg Ulcers: Technical and Clinical Considerations

3. Nametka, Mary, RN, MSN, CS CWS, WCN , Associates in Wound Care, Kenosha, WI May 2001
Antimicrobial Silver Polymer Contact Layer for Treatment of Venous Leg Ulcers

4. Nametka, Mary, RN, MSN, CS CWS, WCN , Associates in Wound Care, Kenosha, WI June 2001
Clinical Protocol for use of Absorbent Silver Antimicrobial Polymer Dressings

5. Nametka, Mary, RN, MSN, CS CWS, WCN , Associates in Wound Care, Kenosha, WI April 2002
Silver Antimicrobial Hydrophilic Dressing Benefits Management of Recurrent Non-healing Wounds

6. Nametka, Mary, RN, MSN, CS CWS, WCN , Associates in Wound Care, Kenosha, WI Sept. 2002
Silver Antimicrobial Absorbent Wound Dressing Can Contribute to Cost Control in Home Care

7. Smith, Latisha M.D ., Ostomy Wound Management, Feb. 2003
Clinical Experience using Silver Antimicrobial Dressings on Venous Stasis Ulcers

8. Gibbins, Bruce Ph.D., Ostomy Wound Management, Feb. 2003
The Antimicrobial Benefits of Silver and the relevance of Microlattice Technology

9. Rose, Susan RN, BSN, CWOCN , Gentiva Health Services, Tuscon, AZ. April 2003
Importance of Assessment and Wound Bed Preparation in the Treatment of Chronic Wounds

10. Paz-Altschul, Oscar M.D., FACS , Desert Regional Medical Center, Palm Springs, CA April 2003
Silver Microlattice Uses in Chronic Wound Care

11. Tamulonis, Ruth RN, MS, CWOCN , Marshalltown Medical & Surgical Center, Marshalltown, IA April 2003 The Use of a Unique Delivery Method of Ionic Silver: A Case Series

12. Brandy, J. Christopher, MD, FACS, Caromont Wound Center Gastonia, NC April 2003
Understanding the Role of Ionic Silver in Wound Bed Preparation

13. Tamulonis, Ruth RN, MS, CWOCN , Marshalltown Medical & Surgical Center, Marshalltown, IA June 2003 A Paradigm Shift in Wound Management

14. Trowsdale, Helen RN, BSN and Olveda, Mary RN, BSN A-Plus Family Care, SanAntonio, TX
Meeting the Challenges for Wounds in Home Care with a Silver Amorphous Hydrogel and Collagen

15. Agbim, Salome ND CNS APRN BC and Miner, Kimberly ND CNS CWCN Wound Care Associates, Englewood, CO Bioburden Control through the use of Silve Anti-moicrobial Gel on Contaminated Stage IV Pressure Ulcer

16. McCord, Shannon MS, RN, CPNP, CNS, CCRN, WOCN, and Bookout, Kimberly BSN, RN, CWOCN, and McLane, Kathleen MSN,RN, CPNP, CWCN, COCN, and Helmrath, Michael MD Texas Children’s Hospital, Houston, TX June 2004 “Use of Silver Dressing with Neonatal Abdominal Evisceration”

17. Marjorie Groom, RN, CWOCN, MSHCA, DAPWCA, Memorial Hosptial Belleville, IL April 2005 “Enhancing Venous Leg Ulcer Health with an Ionic Silver Hydrogel”

18. Barbara Conway Salerno, RN, BSN, CWOCN, Eddy Visiting Nurses, Troy, NY April 2005 “The Use of Controlled-Release Ionic Silver Hydrogel in the Management of Chronic Wounds”

19. Vickie Shuffitt, PT, Scott Hoskinson, MD and Carol Matsumoto, RN, CWOCN Wound Care Program, Maui Memorial Medical Center, Wailuku, HI “Silver Antimicrobial Hydrogel Eradicates Bioburden and Hastens Discharge for Acute Care Facility”

20. Gibbins, Bruce PhD and Karandikar, Bhalchandra PhD AcryMed, Inc., Portland, OR July 2005 “Novel Silver Antimicrobial Treatment”

21. Susan Girolami, BSN, RN, CWOCN Therapy Support, Inc., Cincinnati, OH April 2006 “Combining Ionic Silver Wound Hydrogel and Negative Pressure for Limb Salvage”

22. Cameron Field, DPM and Kenneth Morgan, DPM HealthOne Alliance Presbyterian/St. Lukes, Denver, CO April 2006 “External Fixation Pin Care Protocol Utilizing Ionic Silver Site Dressings”

23. Mary Webb, RN, BSN, MA, CIC San Mateo Medical Center, San Mateo, CA April 2006 “Use of Ionic Silver and Collagen to Reduce Bioburden and Promote Healing for Improved Quality of Life in a Complex Patient”

Man’s knowledge of and use of silver is as old as mankind’s history and there has been volumes of research on silver for many decades. Alfred B. Searle, the founder of Searle Pharmaceuticals, which later became Monsanto Chemical Co., did scientific studies on silver and wrote a book about his research in the 1920s. Anyone claiming that credible research has not been done concerning silver is either intentionally lying or is simply ignorant of the truth and should not be in anything resembling a position of authority.

Categories
Featured Articles

Vitamin D is Now the Most Popular Vitamin

by William B. Grant, Ph.D.

(Orthomolecular Medicine News Service) There were 3600 publications with vitamin D in the title or abstract in 2012 according to PubMed.gov . This brings the total number of publications on vitamin D listed at PubMed to 33,800 (http://www.ncbi.nlm.nih.gov/pubmed). This total compares to 35,100 on vitamin C or ascorbic acid, 21,700 on vitamin E, 19,100 on vitamin A, 17,600 on folate, and 12,000 on vitamin B12. However, since the beginning of 2000, there have been 20,500 publications on vitamin D but only 16,300 publications on vitamin C or ascorbic acid. Thus, vitamin D is the most popular vitamin even though strictly speaking it is not a vitamin. Instead, it is a necessary hormone that can be made in the body through the action of ultraviolet-B (UVB) light. However, it can also be obtained orally through the diet or supplements.

Vitamin D3-5 Cholecalciferol

Top 16 Vitamin D Papers of 2012

The following list of top vitamin D papers for 2012 was selected from a search at PubMed.gov at the end of 2012. The list started out with 60 of candidate papers. This list was then sent to a panel of vitamin D researchers and advocates, who added a few more papers, then voted on the entire list. The final list has papers from a variety of health effects. Many other fine papers could not be included due to space limitations.
4,000 IU vitamin D3 was of great help during pregnancy

A topic that generated considerable interest this year was the role of vitamin D during pregnancy. In a pair of papers, researchers from the Medical University of South Carolina discussed the findings and implications of their randomized controlled trial of vitamin D supplementation during pregnancy [Hollis et al., 2012; Wagner et al., 2012]. Over 300 women were enrolled in the study. Women were assigned to take supplements containing 400, 2000, or 4000 IU/d vitamin D3 or a placebo. No adverse effects were found such as hypercalcemia or hypercalcuria. This study found that it took 4000 IU/d to raise serum 25-hydroxyvitamin D [25(OH)D] levels to about 40 ng/ml (To convert to nmol/l, multiple ng/ml by 2.5.), a nearly optimal level of 1,25-dihydroxyvitamin D. 1,25-dihydroxyvitamin D is the active or hormonal metabolite of vitamin D which among other things controls the expression of several hundred genes. (See Hossein-nezhad and Holick [2012] for a summary of the effects of vitamin D on fetal development.) In the study, those taking the higher vitamin D doses had significantly reduced risk of primary Cesarean section delivery and pre-eclampsia. Other adverse pregnancy outcomes occur with vitamin D deficiency such as premature delivery and low birth weight, but too few women were enrolled in this study to find statistically significant results on these conditions.
Mounting evidence that vitamin D deficiency is an important risk factor for autism

A study from Saudi Arabia examined the relation between serum 25(OH)D level and anti-myelin-associated glycoprotein (anti-MAG) auto-antibodies in autistic children near the age of eight years [Mostafa and Al-Ayadhi, 2012]. There was a very strong inverse relation between the two levels (r = -0.86, p<0.001). The serum 25(OH)D levels in autistic children averaged 19 ng/ml, while that for healthy children averaged 33 ng/ml. Both autistic and healthy children had about six hours of sun exposure per week. The reason that MAG is relevant to autistic children is that MAG is a compound that promotes regeneration of young neurons. Anti-MAG auto-antibodies appear to play a role in some autoimmune disorders relating to neurons through attacking cells that maintain a healthy nervous system. Serum anti-MAG auto-antibodies are strongly related to autism measured with the Childhood Autism Rating Scale. This provides very strong evidence that vitamin D deficiency is associated in some way with autism. Whether increasing serum 25(OH)D levels for those with autism reduces the symptoms of autism remains to be determined.
Low vitamin D during pregnancy is associated with childhood language impairment

A study in Perth, Australia measured serum 25(OH)D levels at 18 weeks into pregnancy, and then measured language impairment of the offspring at 5 and 10 years of age. It found that women with serum 25(OH)D levels below 18 ng/ml had children with twice the risk of clinically significant language difficulties compared to those with 25(OH)D levels above 28 ng/ml. Exactly why is not currently known, but there are many possibilities. It is noted that in the United States in the early 2000s, white women of childbearing age had mean 25(OH)D level of 26 ng/ml while black women of childbearing age had mean 25(OH)D level of 14 ng/ml. Both of these levels are low by current standards. As explained below, skin color is directly relevant to serum vitamin D levels produced by exposure to sunlight.
Higher vitamin D is associated with lower all-cause mortality rates

A topic of interest at the other end of life was the relation of mortality rate to serum 25(OH)D levels. A meta-analysis of 11 observational studies and 60,000 individuals found a reduction in risk over about 10 years for highest vs. lowest category of 25(OH)D level of mortality of 29% [Zittermann et al., 2012]. Comparing graded levels of intake, the reduction in risk was 14% for an increase of 5 ng/ml, 23% for an increase of 10 ng/ml, and 39% for an increase of 20 ng/ml in plasma levels of 25(OH)D, starting from a median of ~11 ng/ml. The participants starting with the lowest levels of serum 25(OH)D received the greatest benefits. Those who started with higher serum levels, closer to optimal (30-40 ng/ml), received less benefit from additional vitamin D. This relation between starting serum 25(OH)D levels and health outcome is not surprising because it is similar to many other health studies. Since 25(OH)D levels likely changed over the duration of the studies, and some participants died of unrelated causes, the actual effect of serum 25(OH)D level on mortality rate is greater than these estimates.
And less cardiovascular disease

Cardiovascular disease is an important contributor to mortality rates. A study of 11,000 patients in Kansas was reported. The patients had a mean age of 58±15 years, a body mass index of 30±8 kg/m2, and a mean serum 25(OH)D level of 24±14 ng/ml [Vacek et al., 2012]. Serum 25(OH)D levels below 30 ng/ml was significantly associated with several cardiovascular-related diseases, including hypertension, coronary artery disease, cardiomyopathy, and diabetes. After a period of 5.5 years, those with serum 25(OH)D levels below 30 ng/ml had twice the mortality rate of those with higher 25(OH)D levels.
And less risk of diabetes mellitus type 2

In a 2.7-year study of 2000 prediabetics, participants with the highest third of 25(OH)D levels (median, 30.1 ng/ml) had a reduction in risk of 28% for developing diabetes mellitus type 2 compared with participants in the lowest third (median, 12.8 ng/ml) [Pittas, 2012].
. . . and less diabetes mellitus type 1 (T1DM)

An observational study on insulin-dependent diabetes mellitus (T1DM) was based on 1000 U.S. military service personnel who developed this disease between 2002 and 2011 [Gorham et al., 2012]. They had provided blood samples between one and ten years prior to developing T1DM. They were carefully matched with another thousand service personnel who did not develop T1DM. There was a reduction in risk of 78% for developing T1DM for those with serum 25(OH)D levels above 24 ng/ml compared to those with levels above 24 ng/ml. This finding is highly statistically significant and is one of the strongest studies of its type.
Fewer bacterial and viral infections

The effect of vitamin D in reducing risk of infections is a topic of increasing interest. Vitamin D reduces risk of infections primarily by strengthening the innate immune system, primarily by inducing production of cathelicidin, a polypeptide with antimicrobial and antiendotoxin properties. It also shifts production of cytokines, a type of cell signaling molecule, away from proinflammatory ones, and has a number of other actions on both the innate and adaptive immune system [Lang et al., 2012]. While the effects of vitamin D have been found mostly for bacterial infections, some have also been reported for viral infections such as influenza, HIV, and hepatitis C [Lang et al., 2012]. In a supplementation study in Sweden involving 140 patients with frequent respiratory tract infections (RTIs) using 4000 IU/d vitamin D3, those in the supplementation group increased their serum 25(OH)D level to 53 ng/ml while those in the placebo group had levels near 27 ng/ml [Bergman et al., 2012]. Those taking vitamin D3 had a 23% reduction in RTIs and a 50% reduction in the number of days using antibiotics.
The benefits of vitamin D in reducing risk of cancer

One of the important and well-documented effects of vitamin D is reduced risk of cancer and increased survival after cancer diagnosis. There were 400 publications on vitamin D and cancer in 2012 according to PubMed.gov. Evidence from ecological, observational and laboratory studies have identified over 15 types of cancer for which higher solar UVB light and/or serum 25(OH)D levels are associated with reduced risk. Two of the papers are especially noteworthy. One, a study from Norway involving 658 patients with either breast, colon, lung, or lymphoma with serum 25(OH)D levels determined within 90 days of cancer diagnosis were followed for up to nine years [Tretli et al., 2012]. Compared to those with levels <18 ng/ml, those who originally had levels >32 ng/ml had a reduction in risk for dying from cancer of 66%. To a cancer patient, this would be a lifeline.

Another cancer paper reported the results of supplementation with 4000 IU/d vitamin D3 of those with low-grade biopsy-assayed prostate cancer [Marshall et al., 2012]. Forty four patients successfully completed the one-year study. Twenty four of the subjects (55%) showed a decrease in the amount of cancer; five subjects (11%) showed no change; 15 subjects (34%) showed an increase. In comparison, with a historical group of 19 patients, only 4 (21%) had reductions in the amount of cancer, 3 (16%) showed no changes, and 12 (63%) showed an increase in cancer. Thus optimal vitamin D supplementation appears to be useful for treating those with cancer.
Falls and fractures

The classical role of vitamin D is to regulate calcium and phosphate absorption and metabolism, leading to strong bones. A pooled analysis of 31,000 persons (mean age, 76 years; 91% women) participating in randomized controlled trials of vitamin D supplementation who developed ~1000 incident hip fractures and ~3800 nonvertebral fractures found that those with the highest intake (median 800 IU/d; range 792-2000) had a 30% reduction in risk of hip fracture and a 14% reduced risk of nonvertebral fracture [Bischoff-Ferrari et al., 2012]. The role of vitamin D in neuromuscular control also plays an important role in reducing risk of falls and fractures.
Skin pigment adapts slowly to changed ultraviolet environment

Jablonski and Chaplin have published a series of papers on human skin pigmentation and its relation to solar ultraviolet radiation (UVR) [Jablonski and Chaplin, 2012]. Their primary thesis is that human skin pigmentation has adapted to UVR conditions where a group of people live for 50 generations, or about a thousand years. UVR from mid-day sunlight produces vitamin D, which provides important protection against many diseases, but sunlight also causes skin cancer and destruction of folate. Dark skin protects against free radical production, damage to DNA, cancer, and loss of folate. Thus, dark skin is best in the tropical planes regions while pale skin is best at high latitude regions. Those with skin adapted to UVB between 23° and 46° have the ability to tan, which is an adaptation to seasonal changes in solar UVB doses. However, in recent times, people have moved or traveled to regions where their skin pigmentation is not suited to the local UVR conditions. They discuss three examples: nutritional rickets, multiple sclerosis and melanoma. Their abstract concludes with this observation: “Low UVB levels and vitamin D deficiencies produced by changes in location and lifestyle pose some of the most serious disease risks of the twenty-first century.”
Vitamin D levels for traditionally living Africans

A study on traditionally living Africans near the equator provides information on “normal” 25(OH)D levels. A paper was published on serum 25(OH)D levels of the Masai and the Hadzabe living near 4° S in Tanzania [Luxwolda et al., 2012]. They have skin type VI (very dark), wear a moderate amount of clothing, spend the major part of the day outdoors, but avoid direct exposure to sunlight when possible. The mean serum 25(OH)D levels of Maasai and Hadzabe were 48 (range 23-67) ng/ml and 44 (range 28-68) ng/ml, respectively. This finding suggests that serum 25(OH)D levels in the range of 40-50 ng/ml may be optimal for human health, which is generally consistent with observational studies for a number of health outcomes.

Vitamin D is made by exposure to sunlight to a significant degree only when the sun is 45 degrees or more above the horizon. At the latitudes of North America and Europe, this is summer midday sunlight between the hours of 11 a.m. and 3 p.m. In the early morning or late afternoon, light-skinned individuals may tan but they hardly get any vitamin D from sunlight. And in the winter, nobody gets much vitamin D from the sun. This explains the health benefits of taking supplements of vitamin D.
Summary and Conclusion

Thus, the evidence that serum 25(OH)D levels above 30-40 ng/ml are required for optimal health continues to mount. It takes 1000-4000 IU/d vitamin D3 to reach these levels in the absence of significant UVB exposure. The evidence comes from a variety of studies including observational and laboratory studies and randomized controlled trials (RCTs). While RCTs are required to demonstrate effectiveness and lack of harm for pharmaceutical drugs which, by definition, are artificial compounds, they should not be required for vitamin D since it is a natural compound important for all animal life including humans. In addition, RCTs on vitamin D are difficult to conduct due to other sources of vitamin D and reduced conversion of vitamin D to 25(OH)D level at higher serum levels. It will take five years or more before large-scale RCTs testing vitamin D supplements are completed and reported. The adverse effects of oral intake of up to 4000 IU/d vitamin D3 and serum 25(OH)D levels up to 100 ng/ml are practically non-existent except for those individuals with conditions that may lead to hypercalcemia. However, some people have experienced hypertension, irritation and tachycardia at doses above 4000 IU/d. Thus, there seems to be little reason to wait for the RCTs before implementing vitamin D policies of higher oral intake and/or moderate UVB exposure and serum 25(OH)D levels. Everyone in North America and Europe should take a supplement of 1000-4000 IU/d of vitamin D in the winter, and those with dark skin or office jobs should take vitamin D all year long. Supplementation with vitamin D is an inexpensive and very effective way to produce huge health benefits.

For further information on vitamin D, the interested reader is directed to these websites: http://www.Grassrootshealth.net, http://www.VitaminDCouncil.org, and http://www.VitaminDWiki.com. Dr. Grant is director of http://www.sunarc.org .
Appreciation is expressed to all the scientists who have reviewed and contributed to this paper:

Barbara J. Boucher, M.D., Queen Mary University of London, Centre for Diabetes, Blizard Institute, London

John J. Cannell, M.D., Vitamin D Council, San Luis Obispo, CA

Brant Cebulla, Vitamin D Council, San Luis Obispo, CA

Cedric F. Garland, Dr. P.H., professor of Family and Preventive Medicine in the UCSD School of Medicine, and member of the Moores UC San Diego Cancer Center, LaJolla, CA

Afrozul Haq, Ph.D., Institutes of Pediatrics and Laboratory Medicine; Sheikh Khalifa Medical City; Abu Dhabi, United Arab Emirates

Robert P. Heaney, M.D., Osteoporosis Research Center, Creighton University Medical Center, Omaha, NE.

Perry Holman, Vitamin D Society, Canada

Johan E. Moan, M.D., Ph.D., Department of Radiation Biology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway

Stefan Pilz, M.D., Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria

Jörg Reichrath, M.D., Ph.D., Department of Dermatology; The Saarland University Hospital; Homburg/Saar, Germany.

And, the Editorial Review Board of the Orthomolecular Medicine News Service, listed further below.

References:

1. Bergman P, Norlin AC, Hansen S, Rekha RS, Agerberth B, Bj”rkhem-Bergman L, Ekstr”m L, Lindh JD, Andersson J. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open. 2012;2(6). pii: e001663.

2. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, St„helin HB, Theiler R, Dawson-Hughes B. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40-9.

3. Gorham ED, Garland CF, Burgi AA, Mohr SB, Zeng K, Hofflich H, Kim JJ, Ricordi C. Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case-control study. Diabetologia. 2012 Dec;55(12):3224-7.

4. Hollis BW, Wagner CL. Vitamin D and pregnancy: Skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int. 2012 May 24. [Epub ahead of print]

5. Hossein-nezhad A, Holick MF. Optimize dietary intake of vitamin D: an epigenetic perspective. Curr Opin Clin Nutr Metab Care. 2012;15(6):567-79.

6. Jablonski NG, Chaplin G. Human skin pigmentation, migration and disease susceptibility. Philos Trans R Soc Lond B Biol Sci. 2012;367(1590):785-92.

7. Lang PO, Samaras N, Samaras D, Aspinall R. How important is vitamin D in preventing infections? Osteoporos Int. 2012 Nov 17. [Epub ahead of print]

8. Luxwolda MF, Kuipers RS, Kema IP, Janneke Dijck-Brouwer DA, Muskiet FA. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr. 2012;108(9):1557-61.

9. Marshall DT, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Host RL, Ambrose LH, Kindy MS, Gattoni-Celli S. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012;97(7):2315-24.

10. Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation. 2012;9:201.

11. Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, Hu FB, Dawson-Hughes B; Diabetes Prevention Program Research Group. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care. 2012;35(3):565-73.

12. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012;23(2):363-70.

13. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012;109(3):359-63.

14. Wagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW. Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients. 2012;4(3):208-30.

15. Whitehouse AJ, Holt BJ, Serralha M, Holt PG, Kusel MM, Hart PH. Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatrics. 2012;129(3):485-93.

16. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91-100.

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

Categories
Featured Articles

Iodine Therapy For Thyroid and Immune Support

by Jonathan Landsman

(Internet) Did you know that doctors once considered iodine to be one of the most beneficial medicines on the planet? Naturally, this was before the pharmaceutical cartel seized control of conventional medicine.

A lack of iodine can make it difficult to properly detoxify the body; create thyroid dysfunction and promote cancer cell growth. In fact, Dr. David Brownstein, iodine expert suggests that most of the population is grossly deficient in this valuable mineral. Find out how iodine therapy can help eliminate dis-ease and promote optimal health – fast!

[Sponsor Products: Lugol’s Liquid Iodine, Thytrophin PMG,  Natural Cellular Immune Booster Protocol]

Is your modern lifestyle robbing you of iodine?

In the 1920s, goiter, or enlarged thyroid gland was a common health problem until we added iodine to salt. But, today, many people have reduced their iodized salt consumption and added chlorine, fluoride and bromide to their diets. The problem is – chlorine, fluoride and bromide lower natural iodine levels within the body by blocking iodine receptors.

Keep in mind, chlorine is commonly used to help “purify” the water in place of iodine. According to conventional dentists – who have been brainwashed by the biggest corporations in the world – fluoride will help “strengthen our teeth” – yeah right. And, bromines replaced iodides in most commercially sold baked goods – since the 1980s. All three of these elements are extremely toxic for the thyroid and dangerous for the rest of our body.

Did you know that bromide can cause depression, headaches, hallucinations or even schizophrenia? And, by the way, there are no long-term studies that show fluoride has any beneficial effect on human health.

The connection between Iodine and breast cancer rates

Observational studies suggest there is a strong connection between thyroid dysfunction and breast cancer. Currently, one in seven American women will develop breast cancer during her lifetime. Yet, thirty years ago, when iodine consumption was much higher than it is today – one in 20 women developed breast cancer. Need I say more?

It’s interesting to note that women in Japan, that consume high levels of dietary iodine, have much lower rates of breast cancer and thyroid problems. But, when those women move to the United States and adopt a Western diet, including much less iodine – their rates of breast cancer and thyroid diseases increase dramatically! Vitamin D; iodine supplementation and fresh, organic whole foods would turn a sick nation around – overnight! It’s time to wake up humanity to a better way of living.

Categories
Ask Utopia Silver

Mountain Cedar Oil Benefits

Ben,
I purchased some cedar oil from you and used 2 dropper fulls of the oil into my dog’s bath soap. I need to say that it smells awesome……..left the dogs with a beautiful glossy coat, and killed every flea on them.  They haven’t scratched for days.
Also, I notice that the instructions on the bottle say it can be used orally, 2 drops.  What are the benefits of cedar oil taken orally?

BTW……………I love the smell.  Reminds me of the hill country.

Gary in Texas

****

Hello Gary,

Juniper and Cedar Oil are claimed to be beneficial for the following:

Arthritis and Rheumatism
Relieving allergies
Reducing inflammation and toxins
Relief of Menstration and PMS systoms
Enhancing circulation
Relieving Gout
Potent anti-bacterial
Thanks for the comments.
Ben in Utopia

Categories
Featured Articles

Saccharin and Sugar Found More Addictive Than Cocaine

by Sayer Ji

(GreenMedInfo.com) Sugar and artificial sweeteners are so accessible, affordable and socially sanctioned, that few consider their habitual consumption to be a problem on the scale of say, addiction to cocaine.  But if recent research is correct their addictive potential could be even worse.

Almost 40 years ago, William Duffy published a book called Sugar Blues which argued that refined sugar is an addictive drug and profoundly damaging to health.  While over 1.6 million copies have been printed since its release in 1975, a common criticism of the book has been that it lacked sufficient scientific support.

Today, William Duffy’s work is finding increasing support in the first-hand, peer-reviewed and published scientific literature itself. Not only is sugar drug-like in effect, but it may be more addictive than cocaine.  Worse, many sugar-free synthetic sweeteners carry with them addictive properties and toxicities that are equal to, or may outweigh those of sugar.

Back in 2007, a revealing study titled, “Intense sweetness surpasses cocaine reward,”  found that when rats were given the option of choosing between water sweetened with saccharin and intravenous cocaine, the large majority of animals (94%) preferred the sweet taste of saccharin. This preference for sweetness was not attributable to its unnatural ability to induce sweetness without calories, because the same preference was found with sucrose; nor was the preference for saccharin overcome by increasing doses of cocaine.

A common argument against the relevance of animal studies like this to human behavior is that rats differ too profoundly from humans. However, even insects like forager bees have been found to respond in a similar way to humans when given cocaine, experiencing an overestimation of the value of the floral resources they collected, with cessation of chronic cocaine treatment causing a withdrawal-like response.

Researchers believe that intense sweetness activates ancient neuroendocrine pathways within the human body, making obsessive consumption and/or craving inevitable. The authors of the cocaine/saccharin study summarized this connection as follows:

“Our findings clearly demonstrate that intense sweetness can surpass cocaine reward, even in drug-sensitized and -addicted individuals. We speculate that the addictive potential of intense sweetness results from an inborn hypersensitivity to sweet tastants. In most mammals, including rats and humans, sweet receptors evolved in ancestral environments poor in sugars and are thus not adapted to high concentrations of sweet tastants. The supranormal stimulation of these receptors by sugar-rich diets, such as those now widely available in modern societies, would generate a supranormal reward signal in the brain, with the potential to override self-control mechanisms and thus to lead to addiction.”

In a previous article, “Is Fructose As Addictive As Alcohol?”, we looked at the addictive properties of isolated fructose in greater depth, including over 70 adverse health effects associated with fructose consumption. It appears that not only does fructose activate a dopamine- and opioid-mediated hedonic pathway within the body, but like excessive alcohol consumption, exacts a significant toll on health in exchange for the pleasure it generates.

The drug-like properties of common beverages and foods, have been the subject of a good deal of research over the past few decades. Wheat and related grains, for instance, are a major food source of opioid peptides. These pharmacologically active compounds, also found in milk, coffee and even lettuce, may even explain why ancient hunters and gatherers took the agrarian leap over 10,000 years ago.  Likely, the transition from the Paleolithic to Neolithic was motivated by a combination of environmental pressures and the inherently addictive properties made accessible and abundant due to the agrarian/animal husbandry mode of civilization. For more on this, read our essay “The Dark Side of Wheat.”

As far as synthetic sweeteners, an accumulating body of toxicological research indicates they have a wide range of unintended, adverse health effects beyond the aforementioned problem of addiction. For a comprehensive list, view our Artificial Sweetener Research page.

One clear implication of these findings is that one is best served consuming natural sweet foods, including honey, or fruit like apples. Not only are these easier to consume in moderation, but they have a profound set of “side benefits” as well. To learn more read our recent explorations of the following alternatives:

Categories
Featured Articles Silver Archives

SILVER RESEARCH BIBLIOGRAPHY

This amazing bibliography was assembled by Dr. A. Bart Flick, the developer of the silver infused wound bandaging material Silverlon.

1. Addicks, L. et al.: Silver in Industry, Reinhold Pub. Corp., NY 401-450, 584-597 (1940). Extensive bibliography on silver for water purification.
2. Akiyama, H. and Okamoto, S., Prophylaxis of indwelling urethral catheter infection: clinical experience with a modified Foley catheter and drainage system, J. Urol., 121, 40, 1979.
3. Avakyan, Z.A., Comparative toxicity of heavy metals for certain microorganisms, Microbiology, 36, 366, 1967.
4. Baenziger, N.C., Description of the structure of three silver-containing drug complexes, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
5. Barranco, S.D. and Colmano, G., Electrical Inhibition of Staphlococcus aureus, Virginia Medical, 646, 1976.
6. Barranco, S.D., Spadaro, J.A., Berger, T.J., and Becker, R.O., In vitro effect of weak direct current on staphlococcus aureus, Clinical Orthopaedics, 100, 250, 1974.
7. Becker, R.O., Electrical treatment of osteomyelitis, Surgery of the Musculoskeletal System, Churchill Livingstone, New York, 1983, 4, 10- 197.
8. Becker, R.O., The effect of electrically generated silver ions on human cells, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
9. Becker, R.O., Effect of anodally generated silver ions on fibrosarcoma cells, Electro- and Magnetobio., 11, 57, 1992.
10. Becker, R.O. and Esper, C., Electrostimulation and undetected malignant tumors, Clin. Orthop., 161, 336, 1981.
11. Becker, R.O. and Spadaro, J.A., Treatment of Orthopedic Infections with electrically generated silver ions, J. Bone Jt. Surgery., 60-A, 871, 1978.
12. Benvenisty, A.I., Tannenbaum, G., Ahlborn, T.N., Fox, C.L., Modak, S., Sampath, L., Reemtsma, K. and Nowygrod, R., Control of prosthetic bacterial infections: evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft, J. Surg. Res., 44,1, 1988.
13. Berger, T.J., Spadaro, J.A., Chapin, S.E., and Becker, R.O., Electrically generated silver ions: quantitative effects on bacterial and mammalian cells, Antimicrob. Agents Chemother., 9, 357, 1976.
14. Berger, T.J., Spadaro, J.A., Bierman, R., Chapin, S.E., and Becker, R.O., Antifungal properties of electrically generated metallic ions, Antimicrob. Agents Chemother., 10, 856, 1976.
15. Block, Seymour, Ed.: Disinfection, Sterilization and Preservation, Chapter 18; Lea & Febiger & Co., Philadelphia, 3rd Ed (1983). Extensive bibliography.
16. Bolton, L., Foleno, B., Means, B., and Petrucelli, S., Direct-current bactericidal effect on intact skin, Antimicrob. Agents Chemother., 18, 137, 1980.
17. Bolton, M., The effects of various metals on the growth of certain bacteria, Am. Phys., ?, 174, ?.
18. Bragg, P.D. and Rainnie, D.J., The effect of silver ions on the respiratory chain of Escherichia coli, Can. J. Microbiol., 20, 883, 1974.
19. Buckley, W.R.: Localized Argyria, Arch. Dermatol. 88: 531-539, 1963.
20. Bult, A., Silver sulfanilamides and related compounds for dermatological application, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
21. Burke, J.F., and Bondoc, C.C., Combined burn therapy utilizing immediate skin allografts and 0.5% AgNO3, Arch. Surg., 97, 716, 1968.
22. Burleson, R., and Eiseman, B., Mechanisms of antibacterial effect of biologic dressings, Ann. Surg., 177, 181, 1973.
23. Burleson, R., and Eiseman, B., Effect of skin dressings and topical antibiotics on healing of partial thickness skin wounds in rats, Surg. Gynecol. Obstet., 136, 958, 1973.
24. Butts, A., The chemical properties of silver, Silver-Economics, Metallurgy, and Use, ed. Butts, A., Krieger, Huntington, NY 1975, 123.
25. Carr, H.S., Wlodkowski, T.J., Rosenkranz, H.S., Silver-sulfadiazine: in vitro antibacterial activity, Antimicrob. Agents Chemother., 4, 585, 1973.
26. Chu, C.S., McManus, A.T., Okerberg, C.V., Mason, A.D., and Pruitt, B.A., Weak direct current accelerates split-thickness graft healing on tangentially excised second-degree burns, J. Burn Care Rehab., 12, 285, 1991.
27. Chu, C.S., McManus, A.T., Mason, A.D., Okerberg, C.V. and Pruitt, B.A., Multiple graft harvestings from deep partial-thickness scald wounds healed under the influence of weak direct current, J. Trauma, 30, 1044, 1990.
28. Chu, C.C., Tsai, W.C., Yao, J.Y., and Chiu, S.S., Newly made antibacterial braided nylon sutures. 1. In vitro qualitative and in vivo preliminary biocompatibility study, J. Biomed. Mater. Res., 21, 1281, 1987
29. Cieszynski, T., Influence of negative electricity on infected callus and osteitis, Acta Morphologica Acad. Sci. Hung., 15, 309, 1967.
30. Collinge, C.A., Goll, G., Seligson, D. and Easly, K.J., Pin tract infections: silver vs. uncoated pins. Orthopedics, 17, 445, 1994.
31. Colmano, G., Medical Applications of monomolecular films of silver, gold and other metals, International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
32. Colmano, G., and Barranco, S.D., Inhibition of staphlococcus aureus on a contaminated electrode in the femur of the rabbitt by low electrical current and its relation to stress, Biophys. J., 15, 28a, 1975.
33. Colmano, G., and Barranco, S.D., Staphlococcus aureus inhibition by low direct current on silver electrodes in the femur of rabbits. Fifty- third Annual meeting of the Virginia Academy of Science, Harrisonburg, VA, May 6-9, 1975.
34. Colmano, G., Edwards, S.S., Lesch, T.E., and Barranco, S.D., Control of Staphlococcus aureus osteomyelitis by microampere activation of metal ions in monomolecular films on stainless steel pins, Fifty-Third Annual Meeting of the Virginia Academy of Science, Harrisonburg, VA, May 6- 9,
35. Colmano, G., Edwards, S.S., and Barranco, S.D. Activation of antibacterial silver coatings on surgical implants by direct current: preliminary studies in rabbits, _., 41, 964, 1980.
36. Colmano, G. , Edwards, S.S., Fainter, L.K. and Barranco, S. D., Electronmicrographs of silver and stainless steel surgical implants coated with silver compounds to control S. Aureus by direct current activation, Twenty-eighth Annual ORS, New Orleans, LA, January 19-21, 1982.
37. Colmano, G., Edwards, S.S. and Barranco, S.L., Effects of low direct current on monomolecular layers of metal stearates coating electrodes in bacterial cultures and surgical implants, Symposium URSI “Ondes Electro-magnetiques et Biologie”, Jouy-en-Josas, Juillet, 1980, 149.
38. Colmano, G., Fainter, L.K., Edwards, S.S., and Barranco, S.D., SEM of S. aureus on current-activated surgical pins coated with silver and silver stearate monolayers, Second Annual BRAGS, Oxford, U.K., Sept. 20-22, 1982.
39. Cowlishaw, J., Spadaro, J.A., Becker, R.A., Inhibition of enzyme induction in e. coli by anadoc silver, J. Bioelectricity, 1, 295, 1982.
40. Crannell, M.Y., Silver in Medicine, Silver-Economics, Metallurgy and Use, ed. Butts, A., Krieger, Huntington, NY, 1975, 227.
41. Cullen, J.M. and Spadaro, J.A., Axonal regeneration in the spinal cord: a role for applied electricity, J. Bioelectricity, 2, 57, 1983.
42. Danscher, G., Rytter Norgaard, J.O., and Baatrup, E., Autometallography: tissue metals demonstrated by a silver enhancement kit, Histochemistry, 86, 465, 1987.
43. Deitch, E.A., Marino, A.A., Gillespie, T.E., and Albright, J.A., Silver-nylon: a new antimicrobial agent, Antimicrob. Agents Chemother., 23, 356, 1983.
44. Deitch, E . A. , Marino, A. A . , Malaleonok, V. , and Alb richt, J . A . , Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity, J. Trauma, 27, 301, 1987.
45. Doherty, P.J. and Williams, D.F., The response of cells and cellular enzymes to silver, presented at Biointeractions ’87, Cambridge, U.K., July 6-8, 1987, 38.
46. Conahue, G.F., The analytical chemistry of silver,…
47. Eichhom, G.L., Shin, Y.A., Butzow, J.J., Clark, P., and Tarien, E., Interaction of metal ions with biological systems, with special reference to silver and gold, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
48. Ellerman-Eriksen, S., Rungby, J., and Morgensen, S.C., Autointerference in silver accumulation in macrophages without affecting phagocytic, migratory or interferon-producing capacity, Virchows Arch., B. 53, 243, 1987.
49. Ersek, R.A., and Navarro, J.A., Maximizing wound healing with silver impregnated porcine xenograft, Today’s OR Nurse, 12, 4, 1990.
50. Ersek, R.A., and Denton, D.R., Cross-linked silver-impregnated skin for burn wound management, J. Burn Care Rehabil., 9, 476, 1988.
51. Ersek, R.A., Gadaria, U., and Denton, D.R., New natural wound dressing, Phys. Ther. Forum, 5, 1, 1986.
52. Ersek, R.A., and Denton, D.R., Silver-impregnated porcine xenograft for damaged or missing skin, Contemp. Surg., 23, 83, 1983.
53. Ersek, R.A., and Denton, D.R., Treatment of skin graft donor sites using silver-impregnated porcine xenograft, Contemp. Orthop., 12, 27, 1986.
54. Ersek, R. A. and Denton, D . R. , Silver-impregnated porcine xenografts for treatment of meshed autografts, Plast. Surg., 13, 482, 1984.
55. ErsekR.A. and Lorio, J., The most indolent ulcers of the skin treated with porcine xenografts and silver ions, Surg. Gynecol. Obstet., 158, 431, 1984.
56. Ersek, R.A., and Denton, D.R., Rhinophyma: treatment with electrocautery and silver-impregnated porcine xenograft, Plast. Reconstr. Surg., 74, 269, 1984.
57. Ersek, R.A., and Hachen, H.J., Porcine xenografts in the treatment of pressure ulcers, Ann. Plast. Surg., 5, 464, 1980.
58. Ersek, R.A., and Denton, D.R., Nail bed avulsions treated with porcine xenografts, J. Hand Surg., 10A, 152, 1985.
59. Ersek, R.A., Denton, D.R., Surak, G.M., and Peters, C.W., Treatment of spider bites with silver-impregnated porcine xenografts, Texas Med., 81, 32, 1985.
60. Falcone, A.E., and Spadaro, J.A., Inhibitory effects of electrically activated silver material on cutaneous wound bacteria, Plast. Reconstruc. Surg., 77, 455, 1986.
61. Flick, A.B., Clinical application of electrical silver iontophoresis, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
62. Flowers III, R.H., Schwenzer, K.J., Kopel, R.F., Fisch, M.J., Tucker, S.I., and Farr, B.M., Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. JAMA, 261, 878, 1989.
63. Fox, C.L., Jr.: Silver Sulfadiazine – A New Topical Therapy for Pseudomonas in Burns; Arch. Surg., 96, 184-188 (1968)
64. Fox, C.L. and Modak, S.M., Mechanism of silver sulfadiazine action on burn wound infections, Antimicrob. Agents Chemother., 5, 582, 1974.
65. Fox, C.L. and Quintiliani, R., Uses of silver sulfadiazine in burns and surgical wounds, Inf. in Surg., 13, 1982.
66. Furst, A., Schlauder, M.C.: Inactivity of Two Noble Metals as Carcinogens; Jour. Environmental Pathology and Toxicology, 1, 51-57
67. Geddes, L.A., and Baker, L.E., Chlorided silver electrodes, Med. Res. Eng., Third quarter, 33, 1967.
68. Golubovich, V.N., and Rabotnova, I.L., Kinetics of growth inhibition in Candida utilis by silver ions, Microbio., 43, 948, 1974.
69. Gristina, A.G., and Costerton, J.W., Bacterial adherence to Biomaterials and tissue, J. Bone Jt. Surg., 67-A, 264, 1985.
70. Gruen, L.C., Interaction of amino acids with silver ions, Biochim. Biophys. Acta, 386, 270, 1975.
71. Haeger, K., Preoperative treatment of leg ulcers with silver spray and aluminum foil, Acta Chir. Scand., 125, 32, 1963.
72. Hall, R.E., Bender, G., and Marquis, R.E., In vitro effects of ion intensity direct current generated silver on eukaryotic cells, J. Oral Maxillofac. Surg., 46, 128, 1988.
73. Hall, R.E., Bender, G., and Marquis, R.E., Inhibitory and cidal antimicrobial actions of electrically generated silver ions, J. Oral Maxillofac. Surg., 45, 779, 1987.
74. Halsted, W.S., Ligature and suture material: the employment of fine silk in preference to catgut and the advantages of transfixion of tissues and vessels in control of hemorrhage – also an account of the introduction of gloves, gutta-percha tissue and silver foil, JAMA, LX, 1119, 1913.
75. Harker, J.M., and Hunter, D.: Occupational Argyria, Br J. Dermatol. 47: 441-455, 1935.
76. Harrison, H.N., Pharmacology of Sulfadiazine silver, Arch. Surg., 114, 281, 1979.
77. Haynes, J.L., and Schulte, T.H., Antibacterial silver surfaces and assessment of needs and opportunities for clinical devices, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
78. Hendry, A.T., and Stewart, I.O., Silver-resistant enterobacteriaceae from hospital patients, Can. J. Microbiol., 25, 915, 1979.
79. Holder, I.A., Knoll, C.A., and Wesselman, J., Norfloxacin and silvernorfloxacin as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp. isolated from burn patients, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
80. Janz, G.J., and Ives, D.J.G., Silver, silver chloride electrodes, Ann. N.Y. Acad. Sci., ?, 210, ?.
81. Jono, K., Yamano, T., Fujmoto, T., and Eguchi, Y.: Bactericidal Action of Active Carbon Coated With Silver and Its Application to Water Purifiers; J. Takeda Research Lab., 33, 9-18, (1974).
82. Jones, A.M., and Bailey, J.A.: Effect of Silver from Cloud Seeding on Rabbits; Water, Air and Soil Pollution, 3/3, 353-363 (1974).
83. Kahn, J., Acetic acid iontophoresis for calcium deposits, Phys. Ther., 57, 658, 1977.
84. Kahn, J., Calcium iontophoresis in suspected myopathy, Phys. Ther.
85. Kirchoff, D.A.: Localized Argyria After a Surgical Endodontic Procedure, Oral Surg. 32: 613-617, 1971.
86. Kramer, S.J., Spadaro, J.A. and Webster, D.A., Antibacterial and osteoinductive properties of demineralized bone matrix treated with silver, Clin. Orthop. Rell. Res., 161, 154, 1981.
87. Kul’skii, L.A., Savluk, O.S., Moroz, O.G., and Kornievakay, L.P.: Disinfection and Conservation of Water with Silver (Russian), Aktualne Vodoprovedeniye Sanitarniy Mikrobiologii, 111 (1973).
88. Landeen, L.K., Yahya, M.T., Kutz, S.M., Gerba, C.P.: Microbiological Evaluation of Copper: Silver Disinfection Units for Use in Swimming Pools; Water Science Tech., 21, 3, 267-270 (1989).
89. Lee, J.V., Hibberd, M.L. and Stanley, S.C.: A Comparison of the Biocidal Properties of Silver Ions and Chloride Against Legionella Species; PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury SP4 OJG, England, DD3/2 AGREPORT (1989).
90. McHugh, G.L., Moellering, R.C., Hopkins, C.C. and Swartz, M.N., Salmonella typhimurium resistant to silver nitrate, chloramphenicol and ampicilin, Lancet, ii, 235, 1975.
91. McNamara, A. and Williams, D.F., Scanning electron microscopy of the metal-tissue interface, Biomaterials, 3, 160, 1982.
92. MacKeen, P.C., Person, S., Warner, S.C., Snipes, W., and Stevens, S.E., Silver-coated nylon fiber as an antibacterial agent, Antimicrob. Agents Chemother., 31, 93, 1987.
93. Madden, M.R., Nolan, E., Finkelstein, J.L., Yurt, R.W., Smeland, J., Goodwin, C.W., Hefton, J., and Staiano-Coico, L., Comparison of an occlusive and semi-occlusive dressing and the effect of the wound exudate upon keratinocyte proliferation, J. Trauma, 29, 924, 1989.
94. Mahan, J., Seligson, D., Henry, S.L., Hynes, P., and Dobbins, J., Factors in pin tract infections, Orthopedics, 14, 305, 1991.
95. Maki, D.G., Cobb, L., Garman, J.K., Shapiro, J.M., Ringer, M., and Helgerson, R.B., An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial, Am. J. Med., 85, 307, 1988.
96. Marchant, R.E., Miller, K.M. and Anderson, J.M., In vivo Leukocyte interactions with Biomer, J. Biomed. Mater. Res., 18, 1169, 1984.
97. Marino, A.A., Malakonok, V., Albright, J.A., Deitch, E.A. and Specian, R.D., Electrochemical properties of silver-nylon fabrics, J. Electrochem. Soc., 132, 68, 1985.
98. Marino, A.A., Electromagnetic fields, cancer and the theory of neuroendocrine related promotion, Bioelectrochem. Bioenergetics, 29- 255, 1993.
99. Marino, A.A., Deitch, E.A., Malakanok, V., Albright, J.A., and Specian, R. D., Electrical augmentation of the antimicrobial activity of silver-nylon fabrics, J. Biol. Phys., 12, 93, 1984.
100. Marino, A.A., Malakanok, V., Deitch, E.A., and Albright, J., Electrical properties of silver-nylon, Third Annual BRAGS, San Francisco, CA, Oct. 2-5, 1983, 36.
101. Marino, A.A., Deitch, E.A. and Albright, J.A., Electric silver antisepsis, IEEE Trans. Biomed. Eng., BME-32, 336, 1985.
102. Marino, A.A., Berger, T.J., Becker, R.O. and Spadaro, J.A., The effects of selected metals on marrow cells in culture, Chem. Biol. Interactions, 9, 217, 1974.
103. Marshall, J.P., and Schneider, R.P.: Systemic Argyria Secondary to Topical Silver Nitrate, Arch. Dermatol. 113: 1077-1079, 1977.
104. Mears, D.C., Electron-probe microanalysis of tissue and cells from implant areas, J. Bone Joint Surg., 48B, 567, 1966.
105. Merril, C.R., Silver-stain detection of proteins separated by polyacrylamide gel electrophoresis, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
106. Modak, S.M. and Fox, F.L., Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa, Biochem. Pharmacol., 22, 2391, 1973.
107. Modak, S.M., Sampath, L., Fox, C.L. Combined use of silver sulfadiazine and antibiotics topically in burn wounds as a possible solution to bacterial resistance, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
108. Modak, S.M., Sampath, Lester and Fox, C.L.: Combined Use of Silver Sulfadiazine and Antibiotics as a Possible Solution to Bacterial Resistance in Burn Wounds; Jour. Burn Care, Vol. 9, No. 4, p. 359 (July/Aug 1988).
109. Modak, S.M. and Fox, C.L. Sulfadiazine silver-resistant Pseudomonas in burns: new topical agents, Arch. Surg., 116, 854, 1981.
110. Nordenstrom, B.E.W. Biokinetic impacts of structure and imaging of the lung: the concept of biologically closed electric circuits. AJR, 145, 1985, 447.
111. Olcott, C.T.: Experimental Argyrosis, IV, Morphological Changes in the Experimental Animal; Am. Jour. of Pathology, 24, 813, (1948).
112. Orr, M.A., Electroplating….
113. Owen, M.C.R.: A Case History of 30 Years of Use With Silver Disinfected Drinking Water; Records of EPA Public Hearing on Revised Primary Drinking Water Regulations held Jan. 28, 1986.
114. Pareilleux, A. and Sizard, N., Lethal effects of electric current on Escherichia coli. Appl. Microbiol., 19, 421, 1970.
115. Pariser, R.J., Generalized argyria: Clinopathologic Features and Histochemistry, Arch. Dermatol., 114; 373-377, 1978.
116. Parker, W.A.: Argyria and Cyanotic Heart Disease, Am. J. Hosp. Pharm. 34: 287-789, 1977.
117. Pharmacology and Therapeutics; Pergamon Press, Series A, Vol. 1. 127-130 (1976).
118. Pifer, J.W., Fridlander, B.R., Kintz, R.T., and Stockdale, D.K., Absence of toxic effects in silver reclamation workers, Scand. J. Work Environ. Health, 15, 210, 1989.
119. Polachek, A.A., Cope, C.B., Willard, B.S., and Enns, T.: Metabolism of Radioactive Silver in a Patient with Carcinoid; Jour. Lab. and Clinical Medicine, 56, 1976-1979 (1949).
120. Rich, L.L., Epinette, W.W., and Wasser, W.K.: Argyria Presenting as Cyanotic Heart Disease, Am J. Cardiol. 30: 290, 1972.
121. Rode, H. de Wet, P.M. and Cywes, S., Germicidal efficacy of silver sulfadiazine in burn wounds. First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
122. Ronchese, F.: Argyrosis and Cyanosis – Melanosis and Cyanosis, Arch. Dermatol. 80: 277-282, 1959.
123. Rosenberg, B., Van Camp, L., and Krigas, T., Inhibition of cell division in Escherrichia coli by electrolysis products from a platinum electrode, Nature, 205, 1965.
124. Rosenkranz, H.S. and Carr, H.S., Silver sulfadiazine: effect on the growth and metabolism of bacteria, Antimicrob. Agents Chemother., 2, 948-951, 1972.
125. Rosenkranz, H. S., Coward, J.E., Wlodkowski, T.J. and Carr, H. S. Properties of silver sulfadiazine-resistant enterobacter cloacae. Antimicrob. Agents Chemother., 5, 199, 1974.
126. Rosenkranz, H.S. and Rosenkranz, S., Silver sulfadiazine: interaction with isolated deoxyribonucleic acid, Antimicrob. Agents. Chemother., 2, 373, 1972.
127. Rosenman, K.D., Moss, A., Kon, S. Argyria: Clinical Implications of Exposure to Silver Nitrate and Silver Oxide; Jour. Occupational Med. 21, 430-435 (1979)
128. Ross, E.M.: Argyria Caused by Chewing of Photographic Film, N Engl. J. Med. 299: 798, 1963.
129. Rowley, B.A., and McKenna, J.M. Electrical current effects on E. coli growth rates (36269), P.S.E.B.M., 139, 929, 1972.
130. Rungby, J., Experimental argyosis: ultrastructural localization of silver in rat eye, Exp. Mol. Pathol., 45, 22, 1986.
131. Rungby, J., Exogenous silver in dorsal root ganglia, peripheral nerve, enteric ganglia and adrenal medulla, Acta Neuropathol. (Berlin), 69, 46, 1986.
132. Rungby, J., Ellerman-Eriksen, S. and Danscher, G., Effects of selenium on toxicity and ultrastructural localization of silver in cultured macrophages, Arch. Toxicol., 61, 40, 1987.
133. Rungby, J., Huffman, P., and Ellermann-Eriksen, S., Silver affects viability and structure of cultured mouse peritoneal macrophages and peroxidative capacity of whole mouse liver, Arch. Toxicol., 59, 408, 1987.
134. Savluk, O.S.: Influence of Anodically Dissolved Silver on the Reticuloendothelial System in Test Animals (Russian); Vodopodgotovka I Ochistka Promyshlennyh Stokov, 10, 72-77 (1973).
135. Schaefer, A.J., K.O. and Johnson, S.M., Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter associated bacteriuria, J. Urol., 139, 69, 1988.
136. Shafik, A., The electrified drain. A new device for sterilizing the field of drainage, Int. Surg., 78, 357, 1993.
137. Sobotka, H., Monomolecular laters,….
138. Spadaro, J.A., Silver anode inhibition of bacteria, First International Conference on Gold and Silver in Medicine, Bethesda, MD, May 13-14, 1987.
139. Spadaro, J.A., Antibacterial effects of silver electrodes, Third Ann. Conf. Eng. Med. Biol. Soc. of IEEE, 1981, 215.
140. Spadaro, J.A., Bioelectric stimulation of bone formation: methods, models and mechanisms, J. Bioelect., 1, 99, 1982.
141. Spadaro, J.A., Electrically stimulated bone growth in animals and man. Clin. Orthop. Rel. Res., 122, 325, 1977.
142. Spadaro, J.A., Bone formation aterial inhibition with silver and other electrodes, Reconstr. Surg. Traumat. 19, 40, 1985.
143. Spadaro, J.A., Electrical osteogenesis – role of the electrode material, Electrical Prop. Bone Cartillage, ?, 189, 1979.
144. Spadaro, J.A., Electrically enhanced osteogenesis at various metal cathodes, J. Biomed. Mat. Res., 16, 861, 1982.
145. Spadaro, J.A. and Becker, R.O., Function of implanted cathodes in electrode-induced bone growth, Med. Biol. Eng. Compuit., 17, 769, 1979.
146. Spadaro, J.A. and Becker, R.O. Some specific cellular effects of electrically injected silver and gold ions, Bioelectrochem. Bioenergetics, 3, 49, 1976.
147. Spadaro, J.A. and Becker, R.O., Size-specific metal complexing sites in native collagen, Nature, 225, 1134, 1970.
148. Spadaro, J.A., Berger, T.J., Barranco, S.D., Chapin, S.E., and Becker, R.O., Antibacterial effects of silver electrodes with weak direct current, Microb. Agents. Chemother., 6, 637, 1974.
149. Spadaro, J.A., Chase, S.E., and Webster, D.A., Bacterial inhibition by electrical activation of percutaneous silver implants, J. Biomed. Mater. Res., 20, 565, 1986.
150. Spadaro, J.A., Kramer, S.J., and Webster, D.A., Antibacterial demineralized bone matrix using silver, 28th Annual ORS, New Orleans, LA, Jan. 19-21, 1982.
151. Spadaro, J.A., Mino, D.E. and Chase, S.E., Bone formation without current: The effect of electrode motion, 30th Annual ORS, Atlanta, GA, Feb. 7-9, 1984, 69.
152. Spadaro, J.A., Mino, D.E., Chase, S.E., Werner, F.W. and Murray, D.G., Mechanical factors in electrode-induced osteogenesis, J. Orthop. Res., 4, 37, 1986.
153. Spadaro, J.A., Webster, D.A., Chapin, S.E., Yuan, H.A., Murray, D.G. and Becker, R.O. Silver-PMMA antibacterial bone cement, 24th Annual ORS, Dallas, TX, Feb. 21-23, 1978, 173.
154. Spadaro, J.A., Webster, D.A. and Chase, S.E., Direct current activation of bacteriostatic silver electrodes, Third Annual BRAGS, San Francisco, CA, Oct. 2-5, 1983.
155. Spadaro, J.A., Webster, D.A., and Becker, R.O., Silver polymethyl methacrylate antibacterial bone cement, Clin. Orthop. 143, 266, 1979.
156. Spadaro, J.A., Webster, D.A., Kovach, J. and Chase, S.E. Antibacterial fixation pins with silver: animal models, 30th Annual ORS, Atlanta, GA, Feb. 7-9, 1984, 335.
157. Tarr, R., Luck, J.V., Snyder, S. and Mills, B., Laboratory experiences with silver electrode bone stimulation, 29th Annual ORS, Anaheim, CA, March 8-10, 1983, 253.
158. Taubes, G., An electrifying possibility, Discover, 7, 23, 1986.
159. Thibodeau, E.A., Handelman, S.L. and Marquis, R.E., Inhibition and killing of oral bacteria by silver ions generated with low intensity direct current, J. Dent. Res., 57, 922, 1978.
160. Thurman, R.B., and Gerba, C.P.: The Molecular Mechanisms of Copper and Silver Ion Disinfection of Bacteria and Viruses; CRC Critical Reviews in Environmental Control, Vol 18, Issue 4 (1989). Extensive bibliography.
161. Tsai, W.C., Chu, C.C., Chin, S.S. and Yao, J.Y., In vitro quantitative study of newly made antibacterial braided nylon sutures, Surg. Gynecol. Obstet., 165, 207, 1987.
162. Vince, D.G. and Williams, D.F., Determination of silver in blood and urine by graphite furnace atomic absorption spectrometry, Analyst, 112, 1627,
163. Vince, D.G. and Williams, D.F., Systemic distribution of metals following implantation, presented at Biointeractions’87, Cambridge, U.K., July 6-8, 1987, 40.
164. Wataha, J.C., Hanks, C.T. and Craig, R.G., The effect of cell monolayer density on the cytotoxicity of metal ions which are released from dental alloys, Dent. Mater., 9, 172, 1993.
165. Watts, S.H., The silver bolt as a means of fixing ununited fractures of certain long bones. Johns Hopkins Hospital Bulletin, April 1904, 135.
166. Webster, D.A., Spadaro, J.A., Kramer, S., and Becker, R.O., Silver anode treatment of chronic osteomyelitis, Clin. Orthop., 1961, 105, 1981.
167. West, H.D., Johnson, A.P., and Johnson, C.W.: The Use of Radioactive Silver for the Detection of Abscesses and Tumors; Jour. Lab. and Clinical Medicine, 34, 1976-1979 (1949).
168. Whalberg, Vivian: The Crede Prophylaxis; Acta Paediatrica Scandinavica, Supplement 295, Stockholm 1982.
169. Williams, D.F. The biocompatibility of silver, First International Conference on Gold and Silver in Medicine, Bethesa, MD, May 13-14, 1987.
170. Williams, D.F., Definitions in Biomaterials, Essevier, Amsterdam, 1987.
171. Williams, D.F., and Doherty, P.J. and Oliver, C., The analysis of inflammatory exudates in the assessment of biocompatibility, presented at Biointeractions ’87, Cambridge, U.K., July 6-7, 1987, 22.
172. Williams, R.L., Doherty, P.J., Vince, D.G., Grashoff, G.J. and Williams, D.F., The biocompatibility of silver, Critical Reviews in Biocompatibility, 5, 221, 1989.
173. Williams, R.L. and Williams, D.F., Albumin absorption on metal surfaces, Biomaterials, 1988.
174. Williams, R.L. and Williams, D.F., The spatial resolution of protein absorption on ogeneous metallic biomaterials, J. Biomed. Mater. Res., 23, 339, 1989.
175. Williams, R.L. and Williams, D.F., The effect of albumin on the wettability of pure metal and metal oxide surfaces, J. Colloid Interface Sci., 126, 596, 1988.
176. Wlodkowski, T.J. and Rosenkranz, H.S., Antifungal activity of silver sulphadiazine, Lancet, 1972, 739.
177. Wysor, M.S. and Zollinhofer, R.E., On the mode of action of silver sulfadiazine, Pathol. Microbiol., 38, 296, 1972.
178. Wysor, M.S. and Zollinhofer, R.E., Silver phosphanilamidopyrimidine, Chemother. 18, 342, 1973.
179. Wysor, M.S. and Zollinhofer, R.E., Reactivity of silver sulfadiazine and the silver uracils with the glucose oxidase of Aspergillus niger, Enzyme, 14, 185, 1972-73.
180. Wysor, M.S. and Zollinhofer, R.E., Deoxyribonucleic acid repair replication in Pseudomonas aeroginosa after sublethal doses of silver sulfadiazine, Path. Microbiol. 39, 434, 1973.
181. Wolcott, L.E., Wheeler, P.C., Hardwicke, H.M. and Rowley, B.A., Accelerated healing of skin ulcers by electrotherapy: preliminary clinical results, Southern Med. J., 62, 795, 1969.
182. Zimmerman, R.L., Piezoelectricity and biological materials, J. Bioelectricity, 1, 265, 1982.
183. Zmener, O. and Dominguez, F., Silver accumulations in periapical granulomas: report of five cases using the scanning electron microscope, the electron microprobe and other complementary methods, Oral Surg. Oral Med. Oral Pathol., 65, 94, 1988.

About:

Dr. Flick has been a leader in the creation of noninvasive healing technologies for more than thirty five years. After receiving his Medical Degree he continued with specialty training in Orthopedic Surgery and Rehabilitation. Following his orthopedic residency Dr. Flick received advanced training in Pain Management, and Wound Management.

Over the years Dr. Flick’s multidisciplinary approach to healing has resulted in numerous patents and the development of innovative medical products that speed the healing process, alleviate pain and reduce swelling. He has worked with the Food and Drug Administration to achieve regulatory approval for numerous medical devices.

As an Senior Research Scientist at the University of Georgia, Dr. Flick has developed several new antimicrobial products that have been shown to be effective in eliminating harmful microbes, bacteria, viruses and fungi from open wounds and ulcerations.

Categories
Customer Testimonials

Crohn’s Disease & Sweat Gland Infection

Hi Utopia,
I became aware of your site & product through a friend that is a toxicologist with a biotoxicity testing firm. He had had a severe bacterial infection of the sweat glands under his armpits.
He had been to a number of doctors & nothing they did was working for him. He decided to go online & search for alternative treatment that would bring him some relief. He quit taking the other medicines the doctors had him on & started taking the advanced colloidal silver. His problem went away & he has not had any additional flare-ups for the past several months. He told me about the ACS & mentioned some of the other things that the testimonials had said it helped them with. One of the things he mentioned was Crohn’s Disease & since a close friend of mine has that disease I went to your site to investigate. I have since referred them & number of others to the site & several have gone to the site & ordered the product. It has helped several of them with some of the things that they took it for as well as some things they didn’t expect it to help.name withheld